Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

NCT00504764

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Hospital General de Alicante Alicante, Spain
  • Hospital Ntra. Sra. Sonsoles Ávila, Avila, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
View all 86 locations
View Trial Details
Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

NCT00891137

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +59 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
View Trial Details
Completed

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

NCT01164163

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +37 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's Hospital Colorado Center for Cancer and Blood Disorders Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

NCT00602771

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia

NCT01910623

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy
  • Az.Ospedaliera S.G.Moscati Avellino, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
View all 38 locations
View Trial Details
Completed

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

NCT00074737

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of California, San Diego La Jolla, California, United States
  • University of Miami Health Center Miami, Florida, United States
  • Washington University Medical Center (Siteman Cancer Center) St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions